Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 12, 2022

Limertinib in Patients With Locally Advanced or Metastatic EGFR T790M–Mutated NSCLC

Journal of Thoracic Oncology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Thoracic Oncology
Efficacy and Safety of Limertinib (ASK120067) in Patients With Locally Advanced or Metastatic EGFR Thr790Met-Mutated NSCLC: A Multicenter, Single-Arm, Phase 2b Study
J Thorac Oncol 2022 Jun 02;[EPub Ahead of Print], Y Shi, B Li, L Wu, Y Pan, Z Pan, Y Liu, Y Fan, Y Ji, J Fang, Q Shi, J Shi, H Gao, Y Hu, X Wang, Z He, R Ma, Y Zhang, D Jiang, Y Bai, Y Zhang, L Huang, T Zhou, H Liu, D Wang, Q Wen, G Chen, A Zang, X Wang, X Zhang, J Hu, R Yang, G Zhang, K Gu, L Wang, Q Wang, Z Wei, Z Li, H Lu, H Zhang, H Chen, T Song

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading